The Drug Hunter’s Assistant: Accelerating Drug Discovery With AI
Are The High Expectations Justified?
The hype around Artificial Intelligence has been deafening in recent years, but real progress can only come when drug discovery culture and regulators catch up with the technology.
You may also be interested in...
Once a pariah because of its price gouging, the new approval represents a change of tack from Horizon.
Often dismissed as a meeting of the global elite, Davos is nevertheless a chance for biopharma leaders to take part in ‘big picture’ debates
Neuroscience could be this decade’s big growth story, but clinical and market access challenges differ to oncology.